., Zelissen PMJ, Lips C.M.J., Korreschaar H.P.F. Fixed dosage of 131I for remnant ablation in patients with differentiated thyroid carcinoma without pre-ablative diagnostic 131I scintigrafy. // Nucl Med Comm; 2000 21: 529-532
Delisle M.J., Schvartz C. 131 iodine and differentiated thyroid cancers. // Ann Endocrinol (Paris); 1996 57 (3) :186-93
Dietlein M., Moka D., Scheidhauer K., et al. Follow-up of differentiated thyroid cancer: comparison of multiple diagnostic tests. // Nucl Med Commun; 2000 21 (11) :991-1000
Dottorini ME, Vignati A., Mazzucchelli L., et al. Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients. // J Nucl Med; 1997 38 (5) :669-75
Driedger A.A., Kidane H.G., Pewe J.E. Impact of I-131 uptake on ablation of post surgical remnants.// International symposium on radioiodine. USA Rochester 1996. Program and Abstracts p.68
Falesi M., Signore A., Ventroni G., et al. Role initial iodine-131 whole-body scan and serum thyroglobulin in differentiated thyriod carcinoma metastases. // J Nucl Med; 1998 39 (9) :1542-6
Farahari J., Parlowsky T., Mader U., et al. Differentiated thyroid cancer in children and adolescents. // Langenbecks Arch Surg; 1998 383 (3): 235 - 239. p> Farina G.P., Pisano M., Baccoli A., et al. Therapeutic strategies in differentiated cancer of the thyroid: total thyroidectomy. // G Chir; 2000 21 (11-12) :469-74
Goslings B.M., Pelikan H.L., Lion J. Resalts of I-131 treatment in advanced stages of differentiated thyroid carcinoma (DTC). // International symposium on radioiodine. USA Rochester 1996. Program and Abstracts p.61
Grant C.S. Operattive and postoperative manegement of the patient with follicular and Hurthler cell carcinoma: Do they differ-//Surg. Clin. North Am. -1995.-Vol.75, № 3. - P.395-403. p> Grigsby P. Cost minimization analysis and utility of pretreatment and posttreatment total body ioidine-131 scans in patients with thyriod carcinoma. // Cancer; 1998 82 (5) :931-5
Grunwald F., Menzel C., Bender H., et al. Redifferentation therapy - induced radioiodine uptake in thyriod cancer. // J Nucl Med; 1998 39 (11) :1903-6
Gulzar Z., Jana S., Young I., et al. Neck and whole-body scanning with 5-mCi dose of (123) I as diagnostic tracer in patients with well-differentiated thyroid cancer. // Endocr Pract; 2001 7 (4) :244-9
Haigh P.I., Ituarte P.H., Wu H.S., et al. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival. // Cancer; 2001 91 (12) :2335-42
Hall P., Mattsson A., Boice J.D. Thyroid cancer after diagnostic administration of iodine-131. // Radiat Res; 1996 145 (1): 86 - 92. p> Hermanska J., Karny M., Zimak J., et al. Improved prediction of therapeutic absorbed doses of radioiodine in the treatment of thyroid carcinoma. // J Nucl Med; 2001 42 (7) :1084-90 ...
